199 related articles for article (PubMed ID: 20163992)
1. Improvement of non-paraneoplastic voltage-gated potassium channel antibody-associated limbic encephalitis without immunosuppressive therapy.
Gast H; Schindler K; Z'graggen WJ; Hess CW
Epilepsy Behav; 2010 Apr; 17(4):555-7. PubMed ID: 20163992
[TBL] [Abstract][Full Text] [Related]
2. Pilomotor seizures and status in non-paraneoplastic limbic encephalitis.
Wieser S; Kelemen A; Barsi P; Vincent A; Borbely C; Rasonyi G; Mueller S; Hess K; Wieser HG; Halasz P
Epileptic Disord; 2005 Sep; 7(3):205-11. PubMed ID: 16162429
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT findings in voltage-gated potassium channel limbic encephalitis.
Kamaleshwaran KK; Iyer RS; Antony J; Radhakrishnan EK; Shinto A
Clin Nucl Med; 2013 May; 38(5):392-4. PubMed ID: 23486322
[TBL] [Abstract][Full Text] [Related]
4. Voltage-gated potassium channel antibody-associated limbic encephalitis.
Saleem A; Sophia R
Age Ageing; 2014 Jul; 43(4):583-5. PubMed ID: 24907351
[TBL] [Abstract][Full Text] [Related]
5. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates.
Ances BM; Vitaliani R; Taylor RA; Liebeskind DS; Voloschin A; Houghton DJ; Galetta SL; Dichter M; Alavi A; Rosenfeld MR; Dalmau J
Brain; 2005 Aug; 128(Pt 8):1764-77. PubMed ID: 15888538
[TBL] [Abstract][Full Text] [Related]
6. Voltage-gated potassium channel antibody limbic encephalitis: a case illustrating the neuropsychiatric and PET/CT features with clinical and imaging follow-up.
Celliers L; Hung TJ; Al-Ogaili Z; Moschilla G; Knezevic W
Australas Psychiatry; 2016 Dec; 24(6):538-540. PubMed ID: 27590077
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology.
Fauser S; Talazko J; Wagner K; Ziyeh S; Jarius S; Vincent A; Schulze-Bonhage A
Acta Neurol Scand; 2005 May; 111(5):338-43. PubMed ID: 15819715
[TBL] [Abstract][Full Text] [Related]
8. Semi-quantitative analysis of cerebral FDG-PET reveals striatal hypermetabolism and normal cortical metabolism in a case of VGKCC limbic encephalitis.
Moloney P; Boylan R; Elamin M; O'Riordan S; Killeen R; McGuigan C
Neuroradiol J; 2017 Apr; 30(2):160-163. PubMed ID: 28424014
[TBL] [Abstract][Full Text] [Related]
9. Voltage-gated potassium channel antibodies in limbic encephalitis.
Pozo-Rosich P; Clover L; Saiz A; Vincent A; Graus F
Ann Neurol; 2003 Oct; 54(4):530-3. PubMed ID: 14520669
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
Malter MP; Helmstaedter C; Urbach H; Vincent A; Bien CG
Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
12. [Limbic encephalitis associated to voltage dependent potassium channel antibodies: report of one case].
Soler B; Godoy J; Mellado P
Rev Med Chil; 2009 May; 137(5):675-9. PubMed ID: 19701558
[TBL] [Abstract][Full Text] [Related]
13. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody.
Thieben MJ; Lennon VA; Boeve BF; Aksamit AJ; Keegan M; Vernino S
Neurology; 2004 Apr; 62(7):1177-82. PubMed ID: 15079019
[TBL] [Abstract][Full Text] [Related]
14. Limbic encephalitis associated with anti-voltage-gated potassium channel complex antibodies as a cause of adult-onset mesial temporal lobe epilepsy.
Toyota T; Akamatsu N; Tsuji S; Nishizawa S
J UOEH; 2014 Jun; 36(2):129-33. PubMed ID: 24930877
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological and FDG-PET profiles in VGKC autoimmune limbic encephalitis.
Dodich A; Cerami C; Iannaccone S; Marcone A; Alongi P; Crespi C; Canessa N; Andreetta F; Falini A; Cappa SF; Perani D
Brain Cogn; 2016 Oct; 108():81-7. PubMed ID: 27566001
[TBL] [Abstract][Full Text] [Related]
16. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.
Vincent A; Buckley C; Schott JM; Baker I; Dewar BK; Detert N; Clover L; Parkinson A; Bien CG; Omer S; Lang B; Rossor MN; Palace J
Brain; 2004 Mar; 127(Pt 3):701-12. PubMed ID: 14960497
[TBL] [Abstract][Full Text] [Related]
17. Binding deficits in memory following medial temporal lobe damage in patients with voltage-gated potassium channel complex antibody-associated limbic encephalitis.
Pertzov Y; Miller TD; Gorgoraptis N; Caine D; Schott JM; Butler C; Husain M
Brain; 2013 Aug; 136(Pt 8):2474-85. PubMed ID: 23757763
[TBL] [Abstract][Full Text] [Related]
18. [Autoimmune limbic encephalitis: importance of early diagnosis and treatment].
van Vliet J; Meulstee J; Hartong EG; Mulleners WM
Ned Tijdschr Geneeskd; 2012; 156(16):A4455. PubMed ID: 22510418
[TBL] [Abstract][Full Text] [Related]
19. Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies.
Pellkofer HL; Kuempfel T; Jacobson L; Vincent A; Derfuss T
J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1407-8. PubMed ID: 20667865
[No Abstract] [Full Text] [Related]
20. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis.
Iranzo A; Graus F; Clover L; Morera J; Bruna J; Vilar C; MartÃnez-Rodriguez JE; Vincent A; SantamarÃa J
Ann Neurol; 2006 Jan; 59(1):178-81. PubMed ID: 16278841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
